Your browser doesn't support javascript.
loading
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.
Moehler, M; Maderer, A; Schimanski, C; Kanzler, S; Denzer, U; Kolligs, F T; Ebert, M P; Distelrath, A; Geissler, M; Trojan, J; Schütz, M; Berie, L; Sauvigny, C; Lammert, F; Lohse, A; Dollinger, M M; Lindig, U; Duerr, E M; Lubomierski, N; Zimmermann, S; Wachtlin, D; Kaiser, A-K; Schadmand-Fischer, S; Galle, P R; Woerns, M.
Afiliação
  • Moehler M; Department of Internal Medicine, Johannes Gutenberg-University of Mainz, Mainz, Germany. Electronic address: markus.moehler@unimedizin-mainz.de.
  • Maderer A; Department of Internal Medicine, Johannes Gutenberg-University of Mainz, Mainz, Germany.
  • Schimanski C; Department of Internal Medicine, Marienhospital Darmstadt, Darmstadt, Germany.
  • Kanzler S; 2nd Department of Medicine, Leopoldina Hospital, Schweinfurt, Germany.
  • Denzer U; 1st Department of Medicine, University Hospital Hamburg, Hamburg, Germany.
  • Kolligs FT; Department of Medicine II, University Hospital Munich, Munich, Germany.
  • Ebert MP; 2nd Department of Medicine, University Hospital Mannheim, Mannheim, Germany.
  • Distelrath A; Tumor Department, Hospital Fulda, Fulda, Germany.
  • Geissler M; Department of Internal Medicine, Hospital Esslingen, Esslingen, Germany.
  • Trojan J; Department of Internal Medicine I, University Hospital Frankfurt, Frankfurt, Germany.
  • Schütz M; Department of Internal Medicine, Johannes Gutenberg-University of Mainz, Mainz, Germany.
  • Berie L; Department of Internal Medicine, Johannes Gutenberg-University of Mainz, Mainz, Germany.
  • Sauvigny C; Department of Internal Medicine, Johannes Gutenberg-University of Mainz, Mainz, Germany.
  • Lammert F; Department of Internal Medicine II, University Hospital Homburg, Homburg, Germany.
  • Lohse A; 1st Department of Medicine, University Hospital Hamburg, Hamburg, Germany.
  • Dollinger MM; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
  • Lindig U; Department of Internal Medicine II, University Hospital Jena, Jena, Germany.
  • Duerr EM; Department of Medicine II, University Hospital Munich, Munich, Germany.
  • Lubomierski N; Department of Internal Medicine I, University Hospital Frankfurt, Frankfurt, Germany.
  • Zimmermann S; Department of Internal Medicine II, University Hospital Homburg, Homburg, Germany.
  • Wachtlin D; Interdisciplinary Center for Clinical Trials of the University Medical Center Mainz, Germany.
  • Kaiser AK; Interdisciplinary Center for Clinical Trials of the University Medical Center Mainz, Germany.
  • Schadmand-Fischer S; Department of Radiology, Johannes Gutenberg-University of Mainz, Mainz, Germany.
  • Galle PR; Department of Internal Medicine, Johannes Gutenberg-University of Mainz, Mainz, Germany.
  • Woerns M; Department of Internal Medicine, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Eur J Cancer ; 50(18): 3125-35, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25446376
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Ductos Biliares Intra-Hepáticos / Neoplasias do Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Neoplasias da Vesícula Biliar Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Eur J Cancer Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Ductos Biliares Intra-Hepáticos / Neoplasias do Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Neoplasias da Vesícula Biliar Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Eur J Cancer Ano de publicação: 2014 Tipo de documento: Article